These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 30953002)

  • 1. AUTS2 isoforms control neuronal differentiation.
    Monderer-Rothkoff G; Tal N; Risman M; Shani O; Nissim-Rafinia M; Malki-Feldman L; Medvedeva V; Groszer M; Meshorer E; Shifman S
    Mol Psychiatry; 2021 Feb; 26(2):666-681. PubMed ID: 30953002
    [TBL] [Abstract][Full Text] [Related]  

  • 2. De novo small deletion affecting transcription start site of short isoform of AUTS2 gene in a patient with syndromic neurodevelopmental defects.
    Martinez-Delgado B; Lopez-Martin E; Lara-Herguedas J; Monzon S; Cuesta I; Juliá M; Aquino V; Rodriguez-Martin C; Damian A; Gonzalo I; Gomez-Mariano G; Baladron B; Cazorla R; Iglesias G; Roman E; Ros P; Tutor P; Mellor S; Jimenez C; Cabrejas MJ; Gonzalez-Vioque E; Alonso J; Bermejo-Sánchez E; Posada M
    Am J Med Genet A; 2021 Mar; 185(3):877-883. PubMed ID: 33346930
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Isolated loss of the AUTS2 long isoform, brain-wide or targeted to Calbindin-lineage cells, generates a specific suite of brain, behavioral, and molecular pathologies.
    Song Y; Seward CH; Chen CY; LeBlanc A; Leddy AM; Stubbs L
    Genetics; 2024 Jan; 226(1):. PubMed ID: 37816306
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Exonic deletions in AUTS2 cause a syndromic form of intellectual disability and suggest a critical role for the C terminus.
    Beunders G; Voorhoeve E; Golzio C; Pardo LM; Rosenfeld JA; Talkowski ME; Simonic I; Lionel AC; Vergult S; Pyatt RE; van de Kamp J; Nieuwint A; Weiss MM; Rizzu P; Verwer LE; van Spaendonk RM; Shen Y; Wu BL; Yu T; Yu Y; Chiang C; Gusella JF; Lindgren AM; Morton CC; van Binsbergen E; Bulk S; van Rossem E; Vanakker O; Armstrong R; Park SM; Greenhalgh L; Maye U; Neill NJ; Abbott KM; Sell S; Ladda R; Farber DM; Bader PI; Cushing T; Drautz JM; Konczal L; Nash P; de Los Reyes E; Carter MT; Hopkins E; Marshall CR; Osborne LR; Gripp KW; Thrush DL; Hashimoto S; Gastier-Foster JM; Astbury C; Ylstra B; Meijers-Heijboer H; Posthuma D; Menten B; Mortier G; Scherer SW; Eichler EE; Girirajan S; Katsanis N; Groffen AJ; Sistermans EA
    Am J Hum Genet; 2013 Feb; 92(2):210-20. PubMed ID: 23332918
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Activity-Dependent Differential Regulation of Auts2 Isoforms In Vitro and In Vivo.
    Pang W; Wang M; Bi Q; Li H; Zhou Q; Ye X; Xiang W; Xiao L
    Mol Neurobiol; 2023 Jun; 60(6):2973-2985. PubMed ID: 36754912
    [TBL] [Abstract][Full Text] [Related]  

  • 6. AUTS2 Regulates RNA Metabolism and Dentate Gyrus Development in Mice.
    Castanza AS; Ramirez S; Tripathi PP; Daza RAM; Kalume FK; Ramirez JM; Hevner RF
    Cereb Cortex; 2021 Aug; 31(10):4808-4824. PubMed ID: 34013328
    [TBL] [Abstract][Full Text] [Related]  

  • 7. AUTS2 disruption causes neuronal differentiation defects in human cerebral organoids through hyperactivation of the WNT/β-catenin pathway.
    Geng Z; Tai YT; Wang Q; Gao Z
    Sci Rep; 2024 Aug; 14(1):19522. PubMed ID: 39174599
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Establishment of human induced pluripotent stem cell line (SDQLCHi060-A) from a patient with AUTS2 syndrome carrying a heterozygous mutation in AUTS2 gene.
    Gao C; Liu Y; Liu N; Li Z; Yang X; Yang Y; Xi Y; Tian J; Gai Z
    Stem Cell Res; 2023 Dec; 73():103242. PubMed ID: 37948839
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Mouse Mutation That Dysregulates Neighboring
    Weisner PA; Chen CY; Sun Y; Yoo J; Kao WC; Zhang H; Baltz ET; Troy JM; Stubbs L
    G3 (Bethesda); 2019 Nov; 9(11):3891-3906. PubMed ID: 31554716
    [No Abstract]   [Full Text] [Related]  

  • 10. NRF1 association with AUTS2-Polycomb mediates specific gene activation in the brain.
    Liu S; Aldinger KA; Cheng CV; Kiyama T; Dave M; McNamara HK; Zhao W; Stafford JM; Descostes N; Lee P; Caraffi SG; Ivanovski I; Errichiello E; Zweier C; Zuffardi O; Schneider M; Papavasiliou AS; Perry MS; Humberson J; Cho MT; Weber A; Swale A; Badea TC; Mao CA; Garavelli L; Dobyns WB; Reinberg D
    Mol Cell; 2021 Nov; 81(22):4663-4676.e8. PubMed ID: 34637754
    [TBL] [Abstract][Full Text] [Related]  

  • 11. AUTS2 Syndrome: Molecular Mechanisms and Model Systems.
    Biel A; Castanza AS; Rutherford R; Fair SR; Chifamba L; Wester JC; Hester ME; Hevner RF
    Front Mol Neurosci; 2022; 15():858582. PubMed ID: 35431798
    [TBL] [Abstract][Full Text] [Related]  

  • 12. WDR68 is essential for the transcriptional activation of the PRC1-AUTS2 complex and neuronal differentiation of mouse embryonic stem cells.
    Wang Q; Geng Z; Gong Y; Warren K; Zheng H; Imamura Y; Gao Z
    Stem Cell Res; 2018 Dec; 33():206-214. PubMed ID: 30448639
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparing a Novel Malformation Syndrome Caused by Pathogenic Variants in
    Pauli S; Berger H; Ufartes R; Borchers A
    Front Cell Dev Biol; 2021; 9():779009. PubMed ID: 34805182
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Polycomb group RING finger proteins 3/5 activate transcription via an interaction with the pluripotency factor Tex10 in embryonic stem cells.
    Zhao W; Huang Y; Zhang J; Liu M; Ji H; Wang C; Cao N; Li C; Xia Y; Jiang Q; Qin J
    J Biol Chem; 2017 Dec; 292(52):21527-21537. PubMed ID: 29054931
    [TBL] [Abstract][Full Text] [Related]  

  • 15. AUTS2 Controls Neuronal Lineage Choice Through a Novel PRC1-Independent Complex and BMP Inhibition.
    Geng Z; Wang Q; Miao W; Wolf T; Chavez J; Giddings E; Hobbs R; DeGraff DJ; Wang Y; Stafford J; Gao Z
    Stem Cell Rev Rep; 2023 Feb; 19(2):531-549. PubMed ID: 36258139
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Deregulation of polycomb repressor complex 1 modifier AUTS2 in T-cell leukemia.
    Nagel S; Pommerenke C; Meyer C; Kaufmann M; Drexler HG; MacLeod RA
    Oncotarget; 2016 Jul; 7(29):45398-45413. PubMed ID: 27322685
    [TBL] [Abstract][Full Text] [Related]  

  • 17. De Novo Pathogenic Variant in
    Bukvic N; De Rinaldis M; Chetta M; Trabacca A; Bassi MT; Marsano RM; Holoubkova L; Rivieccio M; Oro M; Resta N; Kerkhof J; Sadikovic B; Viggiano L
    Genes (Basel); 2024 Jun; 15(7):. PubMed ID: 39062605
    [No Abstract]   [Full Text] [Related]  

  • 18. Two male adults with pathogenic AUTS2 variants, including a two-base pair deletion, further delineate the AUTS2 syndrome.
    Beunders G; de Munnik SA; Van der Aa N; Ceulemans B; Voorhoeve E; Groffen AJ; Nillesen WM; Meijers-Heijboer EJ; Frank Kooy R; Yntema HG; Sistermans EA
    Eur J Hum Genet; 2015 Jun; 23(6):803-7. PubMed ID: 25205402
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Attention Deficit Hyperactivity and Autism Spectrum Disorders as the Core Symptoms of AUTS2 Syndrome: Description of Five New Patients and Update of the Frequency of Manifestations and Genotype-Phenotype Correlation.
    Sanchez-Jimeno C; Blanco-Kelly F; López-Grondona F; Losada-Del Pozo R; Moreno B; Rodrigo-Moreno M; Martinez-Cayuelas E; Riveiro-Alvarez R; Fenollar-Cortés M; Ayuso C; Rodríguez de Alba M; Lorda-Sanchez I; Almoguera B
    Genes (Basel); 2021 Aug; 12(9):. PubMed ID: 34573342
    [TBL] [Abstract][Full Text] [Related]  

  • 20. De novo mutations in FBRSL1 cause a novel recognizable malformation and intellectual disability syndrome.
    Ufartes R; Berger H; Till K; Salinas G; Sturm M; Altmüller J; Nürnberg P; Thiele H; Funke R; Apeshiotis N; Langen H; Wollnik B; Borchers A; Pauli S
    Hum Genet; 2020 Nov; 139(11):1363-1379. PubMed ID: 32424618
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.